Trial record 1 of 1 for:
IMC-F106C-101
Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04262466 |
Recruitment Status :
Recruiting
First Posted : February 10, 2020
Last Update Posted : April 2, 2024
|
Sponsor:
Immunocore Ltd
Information provided by (Responsible Party):
Immunocore Ltd
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Recruiting |
---|---|
Estimated Primary Completion Date : | June 2026 |
Estimated Study Completion Date : | June 2026 |